Loading clinical trials...
Loading clinical trials...
This is a research that will investigate the safety and efficacy of virgin coconut oil (VCO) as an adjunctive therapy for Coronavirus Disease 2019 (COVID-19)
This study will be a randomized controlled trial among hospitalized COVID-19 patients, aged 18 years old and above, admitted at the Philippine General hospital. Patients will be grouped into the following: 1. Group receiving standard of care 2. Group receiving standard of care plus virgin coconut oil (15ml, 3x/day for 2 weeks) as adjunctive therapy. Patients will be observed as regards to primary outcomes such as recovery/resolution of symptoms and duration of hospital stay
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Philippine General Hospital
Manila, National Capital Region, Philippines
Start Date
October 22, 2020
Primary Completion Date
April 9, 2022
Completion Date
April 9, 2022
Last Updated
March 8, 2022
74
ACTUAL participants
Virgin Coconut Oil
DRUG
Lead Sponsor
University of the Philippines
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06355232